Bosh sahifa069620 ā¢ KRX
add
Daewoong Pharma
Yopilish kursi
138Ā 000,00Ā ā©
Kunlik diapazon
137Ā 400,00Ā ā© - 144Ā 700,00Ā ā©
Yillik diapazon
100Ā 100,00Ā ā© - 164Ā 400,00Ā ā©
Bozor kapitalizatsiyasi
1,66Ā trln KRW
OŹ»rtacha hajm
26,25Ā ming
Narx/foyda
66,48
Dividend daromadliligi
0,42%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 367,88Ā mlrd | 1,67% |
Joriy xarajat | 153,50Ā mlrd | -0,07% |
Sof foyda | -12,83Ā mlrd | -119,44% |
Sof foyda marjasi | -3,49 | -119,13% |
Har bir ulushga tushum | ā | ā |
EBITDA | 49,28Ā mlrd | 26,41% |
Amaldagi soliq stavkasi | -17,59% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 116,35Ā mlrd | -15,50% |
Jami aktivlari | 1,98Ā trln | 11,67% |
Jami passivlari | 1,05Ā trln | 22,37% |
Umumiy kapital | 926,98Ā mlrd | ā |
Tarqatilgan aksiyalar | 11,51Ā mln | ā |
Narxi/balansdagi bahosi | 2,00 | ā |
Aktivlardan daromad | 4,61% | ā |
Kapitaldan daromad | 5,66% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -12,83Ā mlrd | -119,44% |
Operatsiyalardan naqd pul | 22,59Ā mlrd | 66,72% |
Sarmoyadan naqd pul | -78,23Ā mlrd | -9,58% |
Moliyadan naqd pul | 60,32Ā mlrd | 113,83% |
Naqd pulning sof oŹ»zgarishi | 8,38Ā mlrd | 125,97% |
BoŹ»sh pul | -56,45Ā mlrd | -8,02% |
Haqida
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Tashkil etilgan
1945
Sayt
Xodimlar soni
1Ā 727
